Lv1
38 积分 2025-06-19 加入
Real-world outcomes of mavacamten for symptomatic obstructive hypertrophic cardiomyopathy: global evidence from COLLIGO-HCM
9天前
已关闭
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
9天前
已完结
Can Vulnerable Plaque Imaging PREVENT Cardiovascular Events?
17天前
已完结
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
2个月前
已完结
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
2个月前
已完结
The Role of the Submitral Apparatus in Hypertrophic Obstructive Cardiomyopathy
3个月前
已关闭
Changes in left ventricular-aortic angulation are associated with the development of obstruction in hypertrophic cardiomyopathy
5个月前
已关闭
Unmasking obstruction in hypertrophic cardiomyopathy with postprandial resting and treadmill stress echocardiography
5个月前
已完结
Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy
5个月前
已关闭
Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy
6个月前
已完结
皖公网安备34019202002308
